Meeting
2020 Gastrointestinal Cancers Symposium
Female representation in clinical trials leading to FDA cancer drug approvals for gastrointestinal (GI) cancers between 2008 to 2018.
Authors
Shehara Ramyalini Mendis
BC Cancer, Vancouver, BC, Canada
Shehara Ramyalini Mendis , Seerat Anand , Arvind Dasari , Joseph M. Unger , Anirudh Gothwal , Lee M. Ellis , Gauri Rajani Varadhachary , Scott Kopetz , Michael J. Overman , Kanwal Pratap Singh Raghav , Jonathan M. Loree
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 809)
Abstract #
809
Poster Bd #
J13
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Mismatch between mortality burden and number of FDA registration trials in highly lethal cancers.
First Author: Bishal Gyawali
Poster
2024 ASCO Genitourinary Cancers Symposium
Disparities in prostate cancer mortality and clinical trial availability across vulnerable populations.
First Author: Rishi Sekar
Poster
2022 ASCO Quality Care Symposium
Survival outcomes by insurance status for patients with cancer ages 18-64 and 65 or older treated in clinical trials.
First Author: Joseph M. Unger
Poster
2022 ASCO Annual Meeting
Gender disparity in authorship of clinical trials leading to cancer drug approvals between 2008 and 2018: The glass ceiling of academic oncology.
First Author: Lynne O. Chapman